Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Pharma/Biotech GTN Summit

Register by September 18th to SAVE $300:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
November 16-18, 2026
Hilton at Penn's LandingPhiladelphia, PA, USA
Group RatesBook Now
Menu
Book
Group Rates

Pharma/Biotech GTN Summit

Gross-to-Net Insights

Stay ahead of evolving pharmaceutical and biotech gross-to-net management through our curated collection of expert interviews, session highlights, and practical insights highlighting topics on rebate management, forecasting accuracy, and optimizing net revenue performance.

get_app

GTN Benchmarking Report - Insights from the 2025 Summit

GTN Benchmarking Report - Insights from the 2025 Summit

Download the PDF today!

At the 2025 Pharma/Biotech Gross-to-Net Summit, industry leaders explored GTN management strategies and cross-functional collaboration across finance, operations, pricing, and market access teams. The goal: equipping attendees with practical strategies to navigate regulatory shifts, optimize forecasting, and leverage technology solutions to address the evolving complexity of GTN.

This benchmarking report compiles insights directly from your peers at the Summit, reflecting the real challenges being faced - from reconciliation and AI integration to operations and benefit redesigns. The data underscores a critical theme: cross-functional collaboration is essential to staying ahead of emerging challenges, and effective GTN management requires alignment across all key stakeholders. GTN is now a team sport.

The pharmaceutical pricing landscape is entering a period of unprecedented change. With the Inflation Reduction Act (IRA) now active and Medicare drug price negotiations underway in 2026, GTN teams face complex challenges in forecasting, compliance, and financial planning. Add evolving Medicaid policies, PBM reforms, and international trade considerations, and the environment becomes even more intricate.

Read the Full Blog Here
Prakash Chainani at Lifestar Pharma - Speaker at Pharma/Biotech GTN Summit

Lifestar Pharma's Journey and the Evolving Generic Pharmaceutical Landscape

"GTN is getting more complicated day by day for generics as it's not easy to forecast certain concessions like price protection and shelf stock adjustments."

We spoke with Prakash Chainani, Vice President of Finance, HR & IT at Lifestar Pharma to learn about the evolving landscape of generic pharmaceuticals.

Read the Full Interview with Prakash